A detailed history of Gateway Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gateway Wealth Partners, LLC holds 774 shares of LLY stock, worth $707,877. This represents 0.22% of its overall portfolio holdings.

Number of Shares
774
Previous 764 1.31%
Holding current value
$707,877
Previous $445 Million 35.3%
% of portfolio
0.22%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $5,922 - $7,922
10 Added 1.31%
774 $602 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $92,958 - $109,586
177 Added 30.15%
764 $445 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $2,455 - $3,282
-7 Reduced 1.18%
587 $275 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $310 - $364
1 Added 0.17%
594 $204 Million
Q4 2022

Feb 15, 2023

BUY
$321.55 - $374.67 $190,679 - $222,179
593 New
593 $217 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gateway Wealth Partners, LLC Portfolio

Follow Gateway Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Wealth Partners, LLC with notifications on news.